California's Proposition 71 contained no requirement that the state actually benefit from the $3 billion program, but the state deserves to receive not only medical benefits of the research, but financial benefits as well, according to the San Francisco Chronicle. Those benefits include patents resulting from the funded research as well as royalties from drugs produced and the specialty companies expected to be spun off from the discoveries.

Related Summaries